Physician profile
Keeran Kumar
NPI 1821153453
$791.96
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $63.88 · 2021: $185 · 2022: $11.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $151.50 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $136.89 | 2019 | |
| Depuy Synthes Sales INC. | $118.44 | 2021 | |
| Globus Medical, INC. | $106.48 | 2019 | |
| Shionogi INC | $41.60 | 2019 | |
| Kaleo, INC. | $36.00 | 2019 | |
| Pacira Therapeutics, INC. | $32.93 | 2019 | |
| Stimwave Technologies Incorporated | $30.26 | 2019 | |
| Abbott Laboratories | $27.83 | 2019 | |
| Si-Bone, INC. | $23.67 | 2020-2021 | |
| Assertio Therapeutics, INC. | $23.59 | 2019 | |
| Biodelivery Sciences International, INC. | $19.46 | 2019 | |
| Nevro Corp. | $18.21 | 2021 | |
| Fidia Pharma USA INC. | $13.52 | 2019 | |
| Medline Industries LP | $11.58 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keeran Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.